New diagnostic imaging solutions to increase operational efficiencies and optimize patient care FUJIFILM Healthcare Americas Corporation, a leader in diagnostic and enterprise imaging solutions, will highlight its latest diagnostic imaging innovations in booth #3300 in South Hall at the Radiological Society of North America (RSNA) 2025 annual meeting, held November 30 to December […]
Source
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Fujifilm to Highlight Cutting-Edge Imaging Innovations at RSNA 2025
-
Novel Fusion Model Combining Radiomics and Deep Learning Features Outperforms Radiologists in Breast Cancer Detection
by Christos Evangelou, MSc, PhD – Medical Writer and Editor In a recent study, researchers at Chongqing Medical University in China developed a fusion model that integrates radiomics features from intratumoral and peritumoral regions with deep transfer learning features to differentiate benign and malignant breast tumors on dynamic contrast-enhanced MRI. In a multicenter retrospective study, the fusion model […]
Source -
Postpartum Headache Shows Rare Pituitary Apoplexy in Woman
A woman develops sudden postpartum headache that steadily worsens and is ultimately diagnosed with pituitary apoplexy linked to an existing pituitary tumour. Medscape UK
-
UK Makes Progress in Treating Upper GI Bleeding
A major UK reaudit shows significant improvements in outcomes for patients with acute upper GI bleeding and highlights clear areas for further progress. Medscape Medical News
-
Why the UK Advised Against Routine Prostate Screening
The UK screening committee has advised against routine PSA testing for all men, warning of potential harms but backing targeted checks for those with BRCA mutations. Medscape News UK
-
Opportunities for Predicting Lung Cancer Screening Nonadherence: A Systematic Review and Meta-Analysis
The low adherence rate to annual lung cancer screening (LCS) reduces potential mortality benefits. Interventions to improve adherence often do not consider individualized risk for nonadherence, which is vital in informing the design of tailored interventions. The authors systematically reviewed the literature and conducted a meta-analysis on predicting LCS nonadherence risk using machine learning.
-
REACHing for Patient-Centered Screening: Leveraging Mammography Pathways to Advance Lung Cancer Prevention
Lung cancer remains the deadliest cancer in the United States, yet most individuals eligible for its only proven screening modality, low-dose CT (LDCT), never undergo it. Although LDCT reduces lung cancer mortality by up to 20%, national uptake has stalled at about 16% for more than a decade [1]. The barriers are multifactorial, encompassing stigma, misinformation, and limited engagement at the point of eligibility [1]. But perhaps the question is not only whom we reach, but where we reach them.
-
Proactive, Prediction-Driven Outreach for Lung Cancer Screening: Development and Feasibility of a Population Management Toolkit
A prediction-driven approach to population management and proactive outreach is feasible and acceptable to clinicians and patients. Further studies should test the impact of this approach on LCS uptake and outcomes.
-
“You Always Worry”: Scan-Related Anxiety Among Patients With Metastatic Lung Cancer
Routine cancer scans (eg, CT, MRI) produce important prognostic information. However, patients may experience distressing “scanxiety” around the time of scans and scan result discussions. The aim of this study was to describe scanxiety and factors affecting it among patients with metastatic lung cancer completing disease-monitoring, postdiagnosis scans.
-
Reliability of Electronic Medical Record to Assess Patient’s Eligibility for Lung Cancer Screening: Analysis of Two Pilot Trials
Accurate smoking history documentation in electronic medical records (EMRs) is essential for determining lung cancer screening (LCS) eligibility. We investigated the completeness of EMR smoking data, its concordance with patients’ self-reports, and its reliability for LCS eligibility after 2021 LCS United States Preventive Services Task Force guideline change.